Found 117 matching trials
Efficacy of Low-Intensity Shockwave Therapy in Treating Radiation Cystitis
EARLY_PHASE1Radiation-induced cystitis is a condition commonly seen in patients who hav...
Location
Ramathibodi Hospital
Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder
PHASE2The study is intended to test efficacy, safety and tolerability of two dose...
SSR240600C Treatment in Women With Overactive Bladder
PHASE2The primary objective of this study is to evaluate the efficacy of SSR24060...
Location
Sanofi-Aventis Aministrative Office
Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
PHASE4This is an investigator-initiated study of safety, efficacy and tolerabilit...
Location
Deaconess Clinic Gateway Health Center
A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder
PHASE3The purpose of this study is to ascertain the clinical results of solifenac...
Location
Multiple Locations
ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)
PHASE2This study is designed to determine the efficacy of escalating doses of ELB...
Location
Private Gynecological Practice
Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome
PHASE4To investigate if oxybutynin ER adding on antimuscarinics is more effective...
Location
Buddhist Tzu Chi General Hospital
Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg
PHASE1The objective of this study was to investigate the single-dose relative bio...
Location
Kendle International Inc.
A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)
PHASE1This study will design an alternative urodynamic platform to better evaluat...
Location
Multiple Locations
Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women
PHASE4The purpose of the study is to assess the impact of treatment with tolterod...
Location
Pfizer Investigational Site